Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer

The Journal of Urology

Volumn 154, Issue 2, 1995, Pages 424-428

  Soloway, Mark S ^a   Sharifi, Roohollah ^a   Wajsman, Zev ^a   McLeod, David ^a   Wood, David P Jr ^a   Puras Baez, Antonio for the Lupron Depot Neoadjuvant Prostate Cancer Study Group ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FLUTAMIDE; GONADORELIN AGONIST; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN BLOOD LEVEL; ARTICLE; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS; DIARRHEA; FOLLOW UP; HOT FLUSH; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL;

AGED; COMBINED MODALITY THERAPY; FLUTAMIDE; FOLLOW-UP STUDIES; HUMANS; LEUPROLIDE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0029059020     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)67067-8     Document Type: Article

References (31)

1. The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection
2. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer
3. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
4. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy
5. Survival of men with clinically localized prostate cancer detected in the eighth decade of life
6. Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer
7. Selection of patients with stage B prostate cancer for radical prostatectomy
8. The role of radical prostatectomy in the treatment of prostate cancer
9. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup
10. Positive margins after radical prostatectomy: correlation with local recurrence and distant progression
11. Residual disease after radical surgery or radiation therapy for prostate cancer: clinical significance and therapeutic implications
12. Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a restrospective study based upon 25 years of experience
13. Hormone ablation therapy as neoadjuvant treatment to radical prostatectomy
14. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate
15. Neoadjuvant hormonal deprivation before radical prostatectomy
16. Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate specific antigen
17. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial
18. Clinical experience with leuprorelin acetate before radiotherapy for prostatic cancer
19. Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostate
20. Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy
21. Luteinizing hormone-releasing hormone downstaging of clinical stage C prostate cancer
22. Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer
23. Neoadjuvant hormonal treatment in clinical stage C prostate cancer
24. Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor
25. Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup
26. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration
27. Leuprorelin acetate depot: results of a multicentre Japanese trial. TAP-144-SR Study Group
28. Multiple advantages of prior and post-radical prostatectomy with combined endocrine therapy
29. Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect): distinction from poor tumor differentiation
30. Pathologic changes associated with androgen deprivation therapy for prostate cancer
31. Radical prostatectomy for clinical stage T1-2 NOMO prostatic adenocarcinoma: long-term results